Kiran Mazumdar-Shaw talks about Biocon’s fallout with Pfizer which was perhaps the company’s most significant event since its insulin analogues breakthrough
Edelweiss Group’s Rashesh Shah recalls the crises he faced in setting up his business, and how he turned them into opportunities
Harsh Mariwala realised if Marico had to get an international thrust, it needed a manager who wasn’t a part of the local business
JX Group’s David Nash talks about what made him give up the status and security of a Western corporation for the uncertainty of a newly-formed, Far Eastern, international oil and gas business
Alok Kejriwal talks about the challenges he faced when he tried selling value-added content to telecom operators and television channels
Onkar Singh Kanwar says his decision to take Charge of Apollo Tyres was instrumental in pulling the company back from the brink of bankruptcy
In an era when iPad apps and videogames practically demand children’s attention, Mattel continues to lead by innovating with its old-school plastic playthings
From assets to valuations, profits to revenues, here is the annual ranking of the 2000 biggest public companies that matter
While most cable networks are off chasing the next Honey Boo Boo, Scripps Networks thrills investors by sticking close to home
Ken Frazier, the pharma firm’s CEO, could make it the world’s greatest drug company again. But first, he needs to leave his own past behind
Nothing will halt Volkswagen chief Martin Winterkorn’s audacious onslaught of the auto business. Not even Europe’s collapsing economy